257 related articles for article (PubMed ID: 18076493)
1. Uncertainties in the CIIT model for formaldehyde-induced carcinogenicity in the rat: a limited sensitivity analysis-I.
Subramaniam RP; Crump KS; Van Landingham C; White P; Chen C; Schlosser PM
Risk Anal; 2007 Oct; 27(5):1237-54. PubMed ID: 18076493
[TBL] [Abstract][Full Text] [Related]
2. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
[TBL] [Abstract][Full Text] [Related]
3. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity analysis of biologically motivated model for formaldehyde-induced respiratory cancer in humans.
Crump KS; Chen C; Fox JF; Van Landingham C; Subramaniam R
Ann Occup Hyg; 2008 Aug; 52(6):481-95. PubMed ID: 18628253
[TBL] [Abstract][Full Text] [Related]
5. Bayesian analysis of a rat formaldehyde DNA-protein cross-link model.
Yang Y; Allen BC; Tan YM; Liao KH; Clewell HJ
J Toxicol Environ Health A; 2010; 73(12):787-806. PubMed ID: 20391121
[TBL] [Abstract][Full Text] [Related]
6. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS
Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of formaldehyde: applications of a model for the arrest of DNA replication by DNA-protein cross-links.
Heck H; Casanova M
Toxicol Appl Pharmacol; 1999 Oct; 160(1):86-100. PubMed ID: 10502505
[TBL] [Abstract][Full Text] [Related]
8. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells.
Monticello TM; Swenberg JA; Gross EA; Leininger JR; Kimbell JS; Seilkop S; Starr TB; Gibson JE; Morgan KT
Cancer Res; 1996 Mar; 56(5):1012-22. PubMed ID: 8640755
[TBL] [Abstract][Full Text] [Related]
9. Incorporating additional biological phenomena into two-stage cancer models.
Sielken RL; Bretzlaff RS; Stevenson DE
Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
[TBL] [Abstract][Full Text] [Related]
10. Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: identification of key issues.
Subramaniam RP; Chen C; Crump KS; Devoney D; Fox JF; Portier CJ; Schlosser PM; Thompson CM; White P
Risk Anal; 2008 Aug; 28(4):907-23. PubMed ID: 18564991
[TBL] [Abstract][Full Text] [Related]
11. Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment.
Small MJ
Risk Anal; 2008 Oct; 28(5):1289-308. PubMed ID: 18844862
[TBL] [Abstract][Full Text] [Related]
12. Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract.
Conolly RB; Kimbell JS; Janszen DB; Miller FJ
Regul Toxicol Pharmacol; 2002 Feb; 35(1):32-43. PubMed ID: 11846634
[TBL] [Abstract][Full Text] [Related]
13. Carcinogenicity of formaldehyde vapor: interim findings in a long-term bioassay of rats and mice.
Swenberg J; Kerns W; Pavkov K; Mitchell R; Gralla EJ
Dev Toxicol Environ Sci; 1980; 8():283-6. PubMed ID: 7308029
[No Abstract] [Full Text] [Related]
14. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment of laboratory rats and mice chronically exposed to formaldehyde vapors.
Brown KG
Risk Anal; 1985 Sep; 5(3):171-80. PubMed ID: 3916550
[TBL] [Abstract][Full Text] [Related]
16. Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity.
Arts JH; Rennen MA; de Heer C
Regul Toxicol Pharmacol; 2006 Mar; 44(2):144-60. PubMed ID: 16413643
[TBL] [Abstract][Full Text] [Related]
17. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
Bogen KT
Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
[TBL] [Abstract][Full Text] [Related]
18. Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat.
Conolly RB; Schroeter J; Kimbell JS; Clewell H; Andersen ME; Gentry PR
Toxicol Sci; 2023 May; 193(1):1-17. PubMed ID: 36912747
[TBL] [Abstract][Full Text] [Related]
19. The role of mechanistic data in dose-response modeling.
Starr TB
Basic Life Sci; 1985; 33():101-24. PubMed ID: 4040362
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis of F344 rat nasal epithelium suggests that the lack of carcinogenic response to glutaraldehyde is due to its greater toxicity compared to formaldehyde.
Hester SD; Barry WT; Zou F; Wolf DC
Toxicol Pathol; 2005; 33(4):415-24. PubMed ID: 16036858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
